nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—ganglion—peripheral nervous system neoplasm	0.0207	0.12	CbGeAlD
Acamprosate—GRIN2C—nerve—peripheral nervous system neoplasm	0.0159	0.0923	CbGeAlD
Acamprosate—GRIN2A—Reelin signaling pathway—MAP1B—peripheral nervous system neoplasm	0.0148	0.0993	CbGpPWpGaD
Acamprosate—GRIN1—ganglion—peripheral nervous system neoplasm	0.013	0.0755	CbGeAlD
Acamprosate—GRIN2B—nerve—peripheral nervous system neoplasm	0.0126	0.0729	CbGeAlD
Acamprosate—GRIN2B—Reelin signaling pathway—MAP1B—peripheral nervous system neoplasm	0.0125	0.0844	CbGpPWpGaD
Acamprosate—GRIN2B—ganglion—peripheral nervous system neoplasm	0.0124	0.072	CbGeAlD
Acamprosate—GRIN2A—nerve—peripheral nervous system neoplasm	0.011	0.0637	CbGeAlD
Acamprosate—GRIN2A—ganglion—peripheral nervous system neoplasm	0.0109	0.063	CbGeAlD
Acamprosate—GRM5—brainstem—peripheral nervous system neoplasm	0.00898	0.052	CbGeAlD
Acamprosate—GRIN2C—brainstem—peripheral nervous system neoplasm	0.00685	0.0396	CbGeAlD
Acamprosate—GRIN2D—brainstem—peripheral nervous system neoplasm	0.00636	0.0368	CbGeAlD
Acamprosate—GRIN1—brainstem—peripheral nervous system neoplasm	0.00567	0.0328	CbGeAlD
Acamprosate—GRIN2B—brainstem—peripheral nervous system neoplasm	0.00541	0.0313	CbGeAlD
Acamprosate—GRIN2A—brainstem—peripheral nervous system neoplasm	0.00473	0.0274	CbGeAlD
Acamprosate—SLC36A1—brainstem—peripheral nervous system neoplasm	0.0047	0.0272	CbGeAlD
Acamprosate—GRM5—cerebellum—peripheral nervous system neoplasm	0.00443	0.0256	CbGeAlD
Acamprosate—GRIN2C—cerebellum—peripheral nervous system neoplasm	0.00338	0.0195	CbGeAlD
Acamprosate—GABRG2—trigeminal ganglion—peripheral nervous system neoplasm	0.00337	0.0195	CbGeAlD
Acamprosate—GRM5—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00323	0.0217	CbGpPWpGaD
Acamprosate—GRIN2D—cerebellum—peripheral nervous system neoplasm	0.00314	0.0182	CbGeAlD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—NF1—peripheral nervous system neoplasm	0.00297	0.02	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.0029	0.0195	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00289	0.0194	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00288	0.0194	CbGpPWpGaD
Acamprosate—GRIN1—cerebellum—peripheral nervous system neoplasm	0.0028	0.0162	CbGeAlD
Acamprosate—GRIN2D—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00268	0.018	CbGpPWpGaD
Acamprosate—GRIN2B—cerebellum—peripheral nervous system neoplasm	0.00267	0.0154	CbGeAlD
Acamprosate—GABRA1—brainstem—peripheral nervous system neoplasm	0.00263	0.0152	CbGeAlD
Acamprosate—GABRB3—trigeminal ganglion—peripheral nervous system neoplasm	0.00259	0.015	CbGeAlD
Acamprosate—GRIN2A—cerebellum—peripheral nervous system neoplasm	0.00233	0.0135	CbGeAlD
Acamprosate—SLC36A1—cerebellum—peripheral nervous system neoplasm	0.00232	0.0134	CbGeAlD
Acamprosate—GRIN2A—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.0022	0.0148	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00192	0.0129	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00187	0.0126	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00164	0.0111	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00163	0.011	CbGpPWpGaD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—peripheral nervous system neoplasm	0.0016	0.0108	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00156	0.0105	CbGpPWpGaD
Acamprosate—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.00155	0.0104	CbGpPWpGaD
Acamprosate—GABRG2—cerebellum—peripheral nervous system neoplasm	0.00147	0.0085	CbGeAlD
Acamprosate—GRM5—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00145	0.00976	CbGpPWpGaD
Acamprosate—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.00144	0.00967	CbGpPWpGaD
Acamprosate—GABRB3—Orphan transporters—COX2—peripheral nervous system neoplasm	0.00134	0.00901	CbGpPWpGaD
Acamprosate—GABRG2—Orphan transporters—COX2—peripheral nervous system neoplasm	0.00132	0.00885	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.0013	0.00873	CbGpPWpGaD
Acamprosate—GABRA1—cerebellum—peripheral nervous system neoplasm	0.0013	0.0075	CbGeAlD
Acamprosate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.00118	0.00794	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—COX2—peripheral nervous system neoplasm	0.00115	0.00773	CbGpPWpGaD
Acamprosate—GABRB3—cerebellum—peripheral nervous system neoplasm	0.00113	0.00653	CbGeAlD
Acamprosate—GRIN1—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00112	0.00754	CbGpPWpGaD
Acamprosate—GRIN2B—ErbB4 signaling events—ERBB2—peripheral nervous system neoplasm	0.00111	0.00744	CbGpPWpGaD
Acamprosate—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.0011	0.00742	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00109	0.00735	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00105	0.00705	CbGpPWpGaD
Acamprosate—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.00103	0.00693	CbGpPWpGaD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.00102	0.00689	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00102	0.00687	CbGpPWpGaD
Acamprosate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.001	0.00675	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.001	0.00674	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000932	0.00627	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000921	0.00619	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000919	0.00618	CbGpPWpGaD
Acamprosate—GRIN2C—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000907	0.0061	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000891	0.00599	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000882	0.00593	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000868	0.00584	CbGpPWpGaD
Acamprosate—GRIN2D—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000843	0.00567	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.000842	0.00566	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000836	0.00562	CbGpPWpGaD
Acamprosate—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000836	0.00562	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000836	0.00562	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000806	0.00542	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000802	0.00539	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0008	0.00538	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000789	0.00531	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00078	0.00525	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.00078	0.00525	CbGpPWpGaD
Acamprosate—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000777	0.00523	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000768	0.00517	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000766	0.00515	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000765	0.00515	CbGpPWpGaD
Acamprosate—GRIN2A—Reelin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000764	0.00514	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.00075	0.00504	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.000734	0.00494	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000732	0.00492	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000726	0.00489	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.000716	0.00481	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000714	0.0048	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000708	0.00476	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000698	0.00469	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000693	0.00466	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.000691	0.00465	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000668	0.00449	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000665	0.00447	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000651	0.00438	CbGpPWpGaD
Acamprosate—GRIN2B—Reelin signaling pathway—AKT1—peripheral nervous system neoplasm	0.00065	0.00437	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000648	0.00436	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00064	0.00431	CbGpPWpGaD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000638	0.00429	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000634	0.00426	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000624	0.0042	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000616	0.00414	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000604	0.00406	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000589	0.00396	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000588	0.00395	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000586	0.00394	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000585	0.00393	CbGpPWpGaD
Acamprosate—GRIN1—EPHB-mediated forward signaling—HRAS—peripheral nervous system neoplasm	0.000557	0.00374	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000557	0.00374	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000548	0.00368	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000542	0.00365	CbGpPWpGaD
Acamprosate—GRIN2B—EPHB-mediated forward signaling—HRAS—peripheral nervous system neoplasm	0.000542	0.00365	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000537	0.00361	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000534	0.00359	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000524	0.00352	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000517	0.00348	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000511	0.00344	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000499	0.00335	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000494	0.00332	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000481	0.00323	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000479	0.00322	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000474	0.00319	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000474	0.00319	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000473	0.00318	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000467	0.00314	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000463	0.00312	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000451	0.00304	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00044	0.00296	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000439	0.00295	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000434	0.00292	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000432	0.00291	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000414	0.00278	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000395	0.00266	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000391	0.00263	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00039	0.00262	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000381	0.00256	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000378	0.00254	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000376	0.00253	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000376	0.00253	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000374	0.00252	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000369	0.00248	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000362	0.00243	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000353	0.00238	CbGpPWpGaD
Acamprosate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000518	CcSEcCtD
Acamprosate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000351	0.000517	CcSEcCtD
Acamprosate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00035	0.000517	CcSEcCtD
Acamprosate—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000514	CcSEcCtD
Acamprosate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000349	0.000514	CcSEcCtD
Acamprosate—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000514	CcSEcCtD
Acamprosate—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000513	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000347	0.00233	CbGpPWpGaD
Acamprosate—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000511	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000345	0.00232	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000344	0.00232	CbGpPWpGaD
Acamprosate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000507	CcSEcCtD
Acamprosate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000344	0.000507	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000505	CcSEcCtD
Acamprosate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000342	0.000505	CcSEcCtD
Acamprosate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000504	CcSEcCtD
Acamprosate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000341	0.000503	CcSEcCtD
Acamprosate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.000502	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00034	0.000501	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000337	0.00227	CbGpPWpGaD
Acamprosate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000337	0.000497	CcSEcCtD
Acamprosate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000497	CcSEcCtD
Acamprosate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000337	0.000496	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000495	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000336	0.00226	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000332	0.00223	CbGpPWpGaD
Acamprosate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.000489	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000331	0.00223	CbGpPWpGaD
Acamprosate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000488	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000485	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000485	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000485	CcSEcCtD
Acamprosate—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000484	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000329	0.00221	CbGpPWpGaD
Acamprosate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000328	0.000484	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000327	0.0022	CbGpPWpGaD
Acamprosate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.000482	CcSEcCtD
Acamprosate—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.00048	CcSEcCtD
Acamprosate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000478	CcSEcCtD
Acamprosate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000325	0.000478	CcSEcCtD
Acamprosate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000324	0.000477	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000324	0.00218	CbGpPWpGaD
Acamprosate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000477	CcSEcCtD
Acamprosate—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000476	CcSEcCtD
Acamprosate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000474	CcSEcCtD
Acamprosate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000322	0.000474	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000321	0.00216	CbGpPWpGaD
Acamprosate—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000473	CcSEcCtD
Acamprosate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000321	0.000473	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000472	CcSEcCtD
Acamprosate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00032	0.000471	CcSEcCtD
Acamprosate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00047	CcSEcCtD
Acamprosate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.000467	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000466	CcSEcCtD
Acamprosate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.000466	CcSEcCtD
Acamprosate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000314	0.000463	CcSEcCtD
Acamprosate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000314	0.000462	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000313	0.0021	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000312	0.0021	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000311	0.000459	CcSEcCtD
Acamprosate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000311	0.000459	CcSEcCtD
Acamprosate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000456	CcSEcCtD
Acamprosate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000309	0.000455	CcSEcCtD
Acamprosate—Pain—Etoposide—peripheral nervous system neoplasm	0.000309	0.000455	CcSEcCtD
Acamprosate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000454	CcSEcCtD
Acamprosate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00045	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000306	0.00205	CbGpPWpGaD
Acamprosate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000305	0.000449	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000304	0.00205	CbGpPWpGaD
Acamprosate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000448	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000448	CcSEcCtD
Acamprosate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000446	CcSEcCtD
Acamprosate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000443	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000441	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000441	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000439	CcSEcCtD
Acamprosate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000297	0.000438	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000437	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000296	0.000436	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000435	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000295	0.000435	CcSEcCtD
Acamprosate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000295	0.000434	CcSEcCtD
Acamprosate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000433	CcSEcCtD
Acamprosate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00043	CcSEcCtD
Acamprosate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.000429	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000291	0.00196	CbGpPWpGaD
Acamprosate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00029	0.000428	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00029	0.00195	CbGpPWpGaD
Acamprosate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.000427	CcSEcCtD
Acamprosate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000287	0.000422	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000287	0.00193	CbGpPWpGaD
Acamprosate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000422	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000422	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000421	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000285	0.00042	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000285	0.00042	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00042	CcSEcCtD
Acamprosate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00042	CcSEcCtD
Acamprosate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00042	CcSEcCtD
Acamprosate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000417	CcSEcCtD
Acamprosate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000283	0.000417	CcSEcCtD
Acamprosate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000283	0.000416	CcSEcCtD
Acamprosate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000416	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000415	CcSEcCtD
Acamprosate—Rash—Vincristine—peripheral nervous system neoplasm	0.000281	0.000414	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000281	0.00189	CbGpPWpGaD
Acamprosate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000281	0.000414	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000413	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000412	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000279	0.00188	CbGpPWpGaD
Acamprosate—Headache—Vincristine—peripheral nervous system neoplasm	0.000279	0.000411	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000408	CcSEcCtD
Acamprosate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.000405	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000404	CcSEcCtD
Acamprosate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000269	0.000397	CcSEcCtD
Acamprosate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000266	0.000392	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000391	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00039	CcSEcCtD
Acamprosate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000265	0.00039	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000389	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000388	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000388	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000386	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MET—peripheral nervous system neoplasm	0.000262	0.00176	CbGpPWpGaD
Acamprosate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000385	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000382	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000259	0.00175	CbGpPWpGaD
Acamprosate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000259	0.000382	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000379	CcSEcCtD
Acamprosate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000376	CcSEcCtD
Acamprosate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000255	0.000376	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MET—peripheral nervous system neoplasm	0.000255	0.00172	CbGpPWpGaD
Acamprosate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000374	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000371	CcSEcCtD
Acamprosate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000369	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.00025	0.00168	CbGpPWpGaD
Acamprosate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000368	CcSEcCtD
Acamprosate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000248	0.000366	CcSEcCtD
Acamprosate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000248	0.000366	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000365	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000247	0.000364	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000362	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00036	CcSEcCtD
Acamprosate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000358	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000358	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000242	0.00163	CbGpPWpGaD
Acamprosate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000355	CcSEcCtD
Acamprosate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000353	CcSEcCtD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000239	0.00161	CbGpPWpGaD
Acamprosate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000239	0.000352	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000351	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000351	CcSEcCtD
Acamprosate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000348	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000236	0.00159	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000235	0.00158	CbGpPWpGaD
Acamprosate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000234	0.000345	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000343	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00034	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000339	CcSEcCtD
Acamprosate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000229	0.000338	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000338	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000338	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000228	0.00154	CbGpPWpGaD
Acamprosate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000336	CcSEcCtD
Acamprosate—Rash—Etoposide—peripheral nervous system neoplasm	0.000227	0.000335	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000227	0.000335	CcSEcCtD
Acamprosate—Headache—Etoposide—peripheral nervous system neoplasm	0.000226	0.000333	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000333	CcSEcCtD
Acamprosate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000332	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000331	CcSEcCtD
Acamprosate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000329	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000328	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000328	CcSEcCtD
Acamprosate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000328	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000222	0.00149	CbGpPWpGaD
Acamprosate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000327	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000327	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000325	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000219	0.00147	CbGpPWpGaD
Acamprosate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000323	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000219	0.00147	CbGpPWpGaD
Acamprosate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000321	CcSEcCtD
Acamprosate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000319	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000316	CcSEcCtD
Acamprosate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000214	0.000316	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000315	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000314	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000312	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000212	0.00142	CbGpPWpGaD
Acamprosate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000311	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000311	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000311	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000311	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00031	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000309	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000307	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000208	0.0014	CbGpPWpGaD
Acamprosate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000305	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000304	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000304	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000303	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000302	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000301	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000204	0.00137	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000203	0.00137	CbGpPWpGaD
Acamprosate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000299	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000298	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000297	CcSEcCtD
Acamprosate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000296	CcSEcCtD
Acamprosate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000295	CcSEcCtD
Acamprosate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000293	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000293	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000199	0.00134	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000292	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000292	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000291	CcSEcCtD
Acamprosate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00029	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000288	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000288	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000288	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000288	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000287	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000194	0.00131	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000286	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000284	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000284	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000191	0.00129	CbGpPWpGaD
Acamprosate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000281	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000279	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000278	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000276	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MET—peripheral nervous system neoplasm	0.000187	0.00126	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000186	0.00125	CbGpPWpGaD
Acamprosate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000274	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000272	CcSEcCtD
Acamprosate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000271	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00027	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00027	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000269	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MET—peripheral nervous system neoplasm	0.000182	0.00122	CbGpPWpGaD
Acamprosate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000268	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000268	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000267	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000266	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00018	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.00018	0.00121	CbGpPWpGaD
Acamprosate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000265	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.00018	0.00121	CbGpPWpGaD
Acamprosate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000263	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000262	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000176	0.00119	CbGpPWpGaD
Acamprosate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000259	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000175	0.00118	CbGpPWpGaD
Acamprosate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000258	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000257	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000173	0.00116	CbGpPWpGaD
Acamprosate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000255	CcSEcCtD
Acamprosate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000255	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000173	0.00116	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000251	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00017	0.00114	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000249	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000168	0.00113	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000248	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000168	0.00113	CbGpPWpGaD
Acamprosate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000246	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000246	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000245	CcSEcCtD
Acamprosate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000244	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000243	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00024	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000238	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000237	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000236	CcSEcCtD
Acamprosate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000236	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000236	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000236	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000157	0.00105	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000227	CcSEcCtD
Acamprosate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000226	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000153	0.00103	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00022	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000219	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000149	0.000999	CbGpPWpGaD
Acamprosate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000218	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000218	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000146	0.000979	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000214	CcSEcCtD
Acamprosate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000211	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000142	0.000954	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000139	0.000937	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000204	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000203	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000138	0.000925	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000137	0.000925	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000137	0.000923	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000137	0.00092	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000137	0.000919	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000137	0.000918	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000135	0.000908	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000135	0.000907	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000134	0.000904	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000198	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000134	0.000903	CbGpPWpGaD
Acamprosate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000197	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000133	0.000895	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000195	CcSEcCtD
Acamprosate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00019	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000189	CcSEcCtD
Acamprosate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000188	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000188	CcSEcCtD
Acamprosate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000187	CcSEcCtD
Acamprosate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000182	CcSEcCtD
Acamprosate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000177	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00012	0.000807	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00012	0.000804	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000175	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000119	0.000798	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000174	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000118	0.000794	CbGpPWpGaD
Acamprosate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000174	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000117	0.000789	CbGpPWpGaD
Acamprosate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000173	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000117	0.000787	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000164	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000107	0.000717	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000106	0.000716	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000104	0.000699	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000104	0.000698	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000103	0.000695	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000101	0.000683	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000101	0.000681	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.0001	0.000676	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.76e-05	0.000657	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.67e-05	0.000651	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	8.87e-05	0.000597	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.87e-05	0.000596	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.11e-05	0.000545	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—peripheral nervous system neoplasm	7.92e-05	0.000533	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.77e-05	0.000523	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.6e-05	0.000511	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.55e-05	0.000508	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.41e-05	0.000498	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—peripheral nervous system neoplasm	6.8e-05	0.000457	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.71e-05	0.000451	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.54e-05	0.00044	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.2e-05	0.000417	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.93e-05	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.24e-05	0.000352	CbGpPWpGaD
